Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci

Abstract

To test the ability of clinical laboratories to detect antimicrobial resistance among enterococci, we sent four vancomycin-resistant enterococcal strains and one β-lactamase-producing enterococcus to all 93 nongovernment, hospital-based clinical laboratories in New Jersey; 76 (82%) participated in the study. Each organism was tested by the laboratory's routine antimicrobial susceptibility testing method. The proportion of laboratories that correctly reported that an isolate was resistant to vancomycin varied according to the resistance level of the isolate: high-level resistance (MIC for Enterococcus faecium = 512 μg/ml), 96% of laboratories correct; moderate-level resistance (MIC for E. faecium = 64 μg/ml), 27% correct; low-level resistance (MIC for Enterococcus faecalis = 32 μg/ml), 16% correct; and intrinsic low-level resistance (MIC for Enterococcus gallinarum = 8 μg/ml), 74% correct. The β- lactamase-producing E. faecalis isolate was identified as resistant to penicillin and ampicillin by 66 and 8% of laboratories, respectively, but only three laboratories recognized that it was a β-lactamase producer. This survey suggests that many laboratories may fail to detect antimicrobial agent-resistant enterococci.